Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-01
DOI
10.1038/s41598-021-86762-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
- (2020) Fara Brasó-Maristany et al. Nature Communications
- Nanoscale Drug Delivery Systems: From Medicine to Agriculture
- (2020) Pablo Vega-Vásquez et al. Frontiers in Bioengineering and Biotechnology
- Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer
- (2020) Jing Wang et al. Frontiers in Oncology
- Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine
- (2019) Domenico Lombardo et al. Journal of Nanomaterials
- Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2019) Sara M. Tolaney et al. JOURNAL OF CLINICAL ONCOLOGY
- Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer
- (2019) Jiahui Peng et al. BIOMATERIALS
- Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update
- (2018) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review
- (2018) Sarwar Hossen et al. Journal of Advanced Research
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells
- (2017) Rusheni Munisvaradass et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines
- (2017) Navideh Haghnavaz et al. Artificial Cells Nanomedicine and Biotechnology
- Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro
- (2016) U. Weissenstein et al. BMC Complementary and Alternative Medicine
- Timed, sequential administration of paclitaxel improves its cytotoxic effectiveness in a cell culture model
- (2016) Viktória Fisi et al. CELL CYCLE
- Bioresponsive polymer coated drug nanorods for breast cancer treatment
- (2016) Tunyaboon Laemthong et al. NANOTECHNOLOGY
- Antibody-drug conjugates: recent advances in conjugation and linker chemistries
- (2016) Kyoji Tsuchikama et al. Protein & Cell
- The role of individual caspases in cell death induction by taxanes in breast cancer cells
- (2015) Michael Jelínek et al. Cancer Cell International
- Organic Carbamates in Drug Design and Medicinal Chemistry
- (2015) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Principles in the design of ligand-targeted cancer therapeutics and imaging agents
- (2015) Madduri Srinivasarao et al. NATURE REVIEWS DRUG DISCOVERY
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
- (2015) Sara M. Tolaney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids
- (2015) Cristina E. Rodríguez et al. PLoS One
- Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation
- (2015) Randall A. Meyer et al. Small
- Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
- (2014) Karlo Perica et al. ACS Nano
- Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
- (2014) Ornchuma Naksuriya et al. BIOMATERIALS
- Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
- (2014) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- Reactive imidazole intermediates: simplified synthetic approach to functional aliphatic cyclic carbonates
- (2014) Johan V. Olsson et al. Polymer Chemistry
- The Next Generation of Antibody Drug Conjugates
- (2014) Fiona Mack et al. SEMINARS IN ONCOLOGY
- Synergistic Targeting of Cell Membrane, Cytoplasm, and Nucleus of Cancer Cells Using Rod-Shaped Nanoparticles
- (2013) Sutapa Barua et al. ACS Nano
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
- (2013) Joel C. Sunshine et al. BIOMATERIALS
- Paclitaxel drug delivery systems
- (2013) Zhiping Zhang et al. Expert Opinion on Drug Delivery
- 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
- (2013) Aron Goldhirsch et al. LANCET
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Particle shape enhances specificity of antibody-displaying nanoparticles
- (2013) Sutapa Barua et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Delivery: Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice (Adv. Funct. Mater. 20/2012)
- (2012) Biana Godin et al. ADVANCED FUNCTIONAL MATERIALS
- The preferential targeting of the diseased microvasculature by disk-like particles
- (2012) Giulia Adriani et al. BIOMATERIALS
- Antibody-Drug Conjugates for the Treatment of Cancer
- (2012) John A. Flygare et al. Chemical Biology & Drug Design
- Polymeric Conjugates for Drug Delivery
- (2012) Nate Larson et al. CHEMISTRY OF MATERIALS
- The Spindle Assembly Checkpoint
- (2012) Pablo Lara-Gonzalez et al. CURRENT BIOLOGY
- The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome
- (2012) Maximilian L. Würstle et al. EXPERIMENTAL CELL RESEARCH
- Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen
- (2012) Andrew J. McCluskey et al. Molecular Oncology
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore
- (2012) Emily A. Foley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lipid Encapsulation of Cationic Polymers in Hybrid Nanocarriers Reduces Their Non-Specific Toxicity to Breast Epithelial Cells
- (2012) Hui Yi Xue et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetic Considerations for Antibody Drug Conjugates
- (2012) Kedan Lin et al. PHARMACEUTICAL RESEARCH
- Analysis of Cell Cycle Position in Mammalian Cells
- (2012) Matthew J. Cecchini et al. Jove-Journal of Visualized Experiments
- Bortezomib interacts synergistically with belinostat in human acute myeloid leukaemia and acute lymphoblastic leukaemia cells in association with perturbations in NF-κB and Bim
- (2011) Yun Dai et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antibody Conjugate Therapeutics: Challenges and Potential
- (2011) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response
- (2011) Erin R. Steenblock et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Bcl-2 family proteins and caspases in the regulation of apoptosis
- (2011) Mohammad Shamsul Ola et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-apoptosis and cell survival: A review
- (2010) Liam Portt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
- (2010) Mary Caldorera-Moore et al. Expert Opinion on Drug Delivery
- Targeted Polymeric Micelle System for Delivery of Combretastatin A4 to Tumor Vasculature In Vitro
- (2010) Yiguang Wang et al. PHARMACEUTICAL RESEARCH
- Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
- (2010) Amr S. Abu Lila et al. PHARMACEUTICAL RESEARCH
- Polymers for Drug Delivery Systems
- (2010) William B. Liechty et al. Annual Review of Chemical and Biomolecular Engineering
- The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function
- (2009) Xinglu Huang et al. BIOMATERIALS
- XIAP as a ubiquitin ligase in cellular signaling
- (2009) S Galbán et al. CELL DEATH AND DIFFERENTIATION
- Restraint of apoptosis during mitosis through interdomain phosphorylation of caspase-2
- (2009) Joshua L Andersen et al. EMBO JOURNAL
- Apoptosis and autophagy: Regulation of caspase-9 by phosphorylation
- (2009) Lindsey A. Allan et al. FEBS Journal
- Control of mitochondrial apoptosis by the Bcl-2 family
- (2009) J. K. Brunelle et al. JOURNAL OF CELL SCIENCE
- The mitochondrial death pathway: a promising therapeutic target in diseases
- (2009) Sanjeev Gupta et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Size and shape effects in the biodistribution of intravascularly injected particles
- (2009) P. Decuzzi et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Preliminary Biological Evaluation of High-Drug-Load Paclitaxel-Antibody Conjugates for Tumor-Targeted Chemotherapy
- (2009) Sherly Quiles et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitochondrial gateways to cancer
- (2009) Lorenzo Galluzzi et al. MOLECULAR ASPECTS OF MEDICINE
- Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery
- (2009) B. Mishra et al. Nanomedicine-Nanotechnology Biology and Medicine
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion
- (2008) Zih-rou HUANG et al. ACTA PHARMACOLOGICA SINICA
- The Receptor-Mediated Endocytosis of Nonspherical Particles
- (2008) P. Decuzzi et al. BIOPHYSICAL JOURNAL
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
- (2008) G. D. Lewis Phillips et al. CANCER RESEARCH
- Polymeric carriers: role of geometry in drug delivery
- (2008) Eric A Simone et al. Expert Opinion on Drug Delivery
- The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows
- (2008) F. Gentile et al. JOURNAL OF BIOMECHANICS
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
- Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
- (2008) Silvia Muro et al. MOLECULAR THERAPY
- A Comprehensive Platform for Ex Vivo T-cell Expansion Based on Biodegradable Polymeric Artificial Antigen-presenting Cells
- (2008) Erin R Steenblock et al. MOLECULAR THERAPY
- Clinical Efficacy of Taxane-Trastuzumab Combination Regimens for HER-2-Positive Metastatic Breast Cancer
- (2008) K. Bullock et al. ONCOLOGIST
- Shape Induced Inhibition of Phagocytosis of Polymer Particles
- (2008) Julie A. Champion et al. PHARMACEUTICAL RESEARCH
- The effect of particle design on cellular internalization pathways
- (2008) S. E. A. Gratton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells
- (2007) C. Schutz et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started